-
1
-
-
77952299529
-
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma
-
Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010; 28: 2151-2158.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2151-2158
-
-
Williamson, D.1
Missiaglia, E.2
De Reynies, A.3
Pierron, G.4
Thuille, B.5
Palenzuela, G.6
-
2
-
-
84863748866
-
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
-
Missiaglia E, Williamson D, Chisholm J, Wirapati P, Pierron G, Petel F et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 2012; 30: 1670-1677.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1670-1677
-
-
Missiaglia, E.1
Williamson, D.2
Chisholm, J.3
Wirapati, P.4
Pierron, G.5
Petel, F.6
-
3
-
-
0034162714
-
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells
-
Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 2000; 14: 574-584. (Pubitemid 30159776)
-
(2000)
Genes and Development
, vol.14
, Issue.5
, pp. 574-584
-
-
Puri, P.L.1
Wu, Z.2
Zhang, P.3
Wood, L.D.4
Bhakta, K.S.5
Han, J.6
Feramisco, J.R.7
Karin, M.8
Wang, J.Y.J.9
-
4
-
-
54549119169
-
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma
-
Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008; 14: 369-381.
-
(2008)
Cancer Cell
, vol.14
, pp. 369-381
-
-
Wang, H.1
Garzon, R.2
Sun, H.3
Ladner, K.J.4
Singh, R.5
Dahlman, J.6
-
5
-
-
68849118992
-
The musclespecific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation
-
Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M et al. The musclespecific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009; 119: 2366-2378.
-
(2009)
J Clin Invest
, vol.119
, pp. 2366-2378
-
-
Taulli, R.1
Bersani, F.2
Foglizzo, V.3
Linari, A.4
Vigna, E.5
Ladanyi, M.6
-
6
-
-
84859569795
-
Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo
-
Raimondi L, Ciarapica R, De Salvo M, Verginelli F, Gueguen M, Martini C et al. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. Cell Death Differ 2012; 19: 871-881.
-
(2012)
Cell Death Differ
, vol.19
, pp. 871-881
-
-
Raimondi, L.1
Ciarapica, R.2
De Salvo, M.3
Verginelli, F.4
Gueguen, M.5
Martini, C.6
-
7
-
-
84870169122
-
Memories from the polycomb group proteins
-
Lanzuolo C, Orlando V. Memories from the polycomb group proteins. Annu Rev Genet 2012; 46: 561-589.
-
(2012)
Annu Rev Genet
, vol.46
, pp. 561-589
-
-
Lanzuolo, C.1
Orlando, V.2
-
8
-
-
78751662908
-
The Polycomb complex PRC2 and its mark in life
-
Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343-349.
-
(2011)
Nature
, vol.469
, pp. 343-349
-
-
Margueron, R.1
Reinberg, D.2
-
9
-
-
84876076090
-
Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation
-
Woodhouse S, Pugazhendhi D, Brien P, Pell JM. Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation. J Cell Sci 2012; 126: 565-579.
-
(2012)
J Cell Sci
, vol.126
, pp. 565-579
-
-
Woodhouse, S.1
Pugazhendhi, D.2
Brien, P.3
Pell, J.M.4
-
10
-
-
79955459714
-
Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells
-
Juan AH, Derfoul A, Feng X, Ryall JG, Dell'Orso S, Pasut A et al. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev 2011; 25: 789-794.
-
(2011)
Genes Dev
, vol.25
, pp. 789-794
-
-
Juan, A.H.1
Derfoul, A.2
Feng, X.3
Ryall, J.G.4
Dell'Orso, S.5
Pasut, A.6
-
11
-
-
7544230144
-
The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation
-
DOI 10.1101/gad.1241904
-
Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18: 2627-2638. (Pubitemid 39453102)
-
(2004)
Genes and Development
, vol.18
, Issue.21
, pp. 2627-2638
-
-
Caretti, G.1
Di Padova, M.2
Micales, B.3
Lyons, G.E.4
Sartorelli, V.5
-
12
-
-
35348950607
-
Functional Interdependence at the Chromatin Level between the MKK6/p38 and IGF1/PI3K/AKT Pathways during Muscle Differentiation
-
DOI 10.1016/j.molcel.2007.08.021, PII S1097276507005916
-
Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M et al. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 2007; 28: 200-213. (Pubitemid 47599998)
-
(2007)
Molecular Cell
, vol.28
, Issue.2
, pp. 200-213
-
-
Serra, C.1
Palacios, D.2
Mozzetta, C.3
Forcales, S.V.4
Morantte, I.5
Ripani, M.6
Jones, D.R.7
Du, K.8
Jhala, U.S.9
Simone, C.10
Puri, P.L.11
-
13
-
-
84856237597
-
Polycomb protein Ezh1 promotes RNA polymerase II elongation
-
Mousavi K, Zare H, Wang AH, Sartorelli V. Polycomb protein Ezh1 promotes RNA polymerase II elongation. Mol Cell 2012; 45: 255-262.
-
(2012)
Mol Cell
, vol.45
, pp. 255-262
-
-
Mousavi, K.1
Zare, H.2
Wang, A.H.3
Sartorelli, V.4
-
14
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-629.
-
(2002)
Nature
, vol.419
, pp. 624-629
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
Barrette, T.R.4
Kumar-Sinha, C.5
Sanda, M.G.6
-
15
-
-
0142105414
-
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
-
DOI 10.1093/emboj/cdg542
-
Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. Embo J 2003; 22: 5323-5335. (Pubitemid 37279943)
-
(2003)
EMBO Journal
, vol.22
, Issue.20
, pp. 5323-5335
-
-
Bracken, A.P.1
Pasini, D.2
Capra, M.3
Prosperini, E.4
Colli, E.5
Helin, K.6
-
16
-
-
9144226103
-
Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 Gene
-
Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 2003; 5: 481-488. (Pubitemid 38045085)
-
(2003)
Neoplasia
, vol.5
, Issue.6
, pp. 481-488
-
-
Raaphorst, F.M.1
Meijer, C.J.L.M.2
Fieret, E.3
Blokzijl, T.4
Mommers, E.5
Buerger, H.6
Packeisen, J.7
Sewalt, R.A.B.8
Otte, A.P.9
Van Diest, P.J.10
-
17
-
-
77955372421
-
Polycomb target genes are silenced in multiple myeloma
-
Kalushkova A, Fryknas M, Lemaire M, Fristedt C, Agarwal P, Eriksson M et al. Polycomb target genes are silenced in multiple myeloma. PLoS One 2010; 5: e11483.
-
(2010)
PLoS One
, vol.5
-
-
Kalushkova, A.1
Fryknas, M.2
Lemaire, M.3
Fristedt, C.4
Agarwal, P.5
Eriksson, M.6
-
18
-
-
77956277833
-
EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients
-
Rao ZY, Cai MY, Yang GF, He LR, Mai SJ, Hua WF et al. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Carcinogenesis 2010; 31: 1576-1583.
-
(2010)
Carcinogenesis
, vol.31
, pp. 1576-1583
-
-
Rao, Z.Y.1
Cai, M.Y.2
Yang, G.F.3
He, L.R.4
Mai, S.J.5
Hua, W.F.6
-
19
-
-
84855433971
-
Polycomb repressor complex-2 is a novel target for mesothelioma therapy
-
Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P et al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res 2011; 18: 77-90.
-
(2011)
Clin Cancer Res
, vol.18
, pp. 77-90
-
-
Kemp, C.D.1
Rao, M.2
Xi, S.3
Inchauste, S.4
Mani, H.5
Fetsch, P.6
-
20
-
-
36349017912
-
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
-
DOI 10.1158/0008-5472.CAN-07-2498
-
Yu J, Yu J, Rhodes DR, Tomlins SA, Cao X, Chen G et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res 2007; 67: 10657-10663. (Pubitemid 350145890)
-
(2007)
Cancer Research
, vol.67
, Issue.22
, pp. 10657-10663
-
-
Yu, J.1
Yu, J.2
Rhodes, D.R.3
Tomlins, S.A.4
Cao, X.5
Chen, G.6
Mehra, R.7
Wang, X.8
Ghosh, D.9
Shah, R.B.10
Varambally, S.11
Pienta, K.J.12
Chinnaiyan, A.M.13
-
21
-
-
73649102464
-
EZH2 is essential for glioblastoma cancer stem cell maintenance
-
Suva ML, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle JC et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res 2009; 69: 9211-9218.
-
(2009)
Cancer Res
, vol.69
, pp. 9211-9218
-
-
Suva, M.L.1
Riggi, N.2
Janiszewska, M.3
Radovanovic, I.4
Provero, P.5
Stehle, J.C.6
-
22
-
-
77950866779
-
Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
-
Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 2010; 17: 801-810.
-
(2010)
Cell Death Differ
, vol.17
, pp. 801-810
-
-
Wu, Z.L.1
Zheng, S.S.2
Li, Z.M.3
Qiao, Y.Y.4
Aau, M.Y.5
Yu, Q.6
-
23
-
-
80053935847
-
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
-
Wu Z, Lee ST, Qiao Y, Li Z, Lee PL, Lee YJ et al. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differ 2011; 18: 1771-1779.
-
(2011)
Cell Death Differ
, vol.18
, pp. 1771-1779
-
-
Wu, Z.1
Lee, S.T.2
Qiao, Y.3
Li, Z.4
Lee, P.L.5
Lee, Y.J.6
-
24
-
-
84855392434
-
EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR
-
Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS et al. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2011; 72: 315-324.
-
(2011)
Cancer Res
, vol.72
, pp. 315-324
-
-
Wang, C.1
Liu, Z.2
Woo, C.W.3
Li, Z.4
Wang, L.5
Wei, J.S.6
-
25
-
-
70350494322
-
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
-
Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 2009; 114: 2733-2743.
-
(2009)
Blood
, vol.114
, pp. 2733-2743
-
-
Fiskus, W.1
Wang, Y.2
Sreekumar, A.3
Buckley, K.M.4
Shi, H.5
Jillella, A.6
-
26
-
-
84871841675
-
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
-
Qi W, Chan H, Teng L, Li L, Chuai S, Zhang R et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 2012; 109: 21360-21365.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 21360-21365
-
-
Qi, W.1
Chan, H.2
Teng, L.3
Li, L.4
Chuai, S.5
Zhang, R.6
-
27
-
-
84867632489
-
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
-
Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 2012; 8: 890-896.
-
(2012)
Nat Chem Biol
, vol.8
, pp. 890-896
-
-
Knutson, S.K.1
Wigle, T.J.2
Warholic, N.M.3
Sneeringer, C.J.4
Allain, C.J.5
Klaus, C.R.6
-
28
-
-
84869215617
-
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells
-
Fiskus W, Rao R, Balusu R, Ganguly S, Tao J, Sotomayor E et al. Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells. Clin Cancer Res 2012; 18: 6227-6238.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 6227-6238
-
-
Fiskus, W.1
Rao, R.2
Balusu, R.3
Ganguly, S.4
Tao, J.5
Sotomayor, E.6
-
29
-
-
84870573126
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
-
McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012; 492: 108-112.
-
(2012)
Nature
, vol.492
, pp. 108-112
-
-
McCabe, M.T.1
Ott, H.M.2
Ganji, G.3
Korenchuk, S.4
Thompson, C.5
Van Aller, G.S.6
-
30
-
-
84896691188
-
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
-
Walters ZS, Villarejo-Balcells B, Olmos D, Buist TWS, Missiaglia E, Allen R et al. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Oncogene 2014; 33: 1148-1157.
-
(2014)
Oncogene
, vol.33
, pp. 1148-1157
-
-
Walters, Z.S.1
Villarejo-Balcells, B.2
Olmos, D.3
Buist, T.W.S.4
Missiaglia, E.5
Allen, R.6
-
31
-
-
60749126576
-
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma
-
Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R et al. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 2009; 8: 172-175.
-
(2009)
Cell Cycle
, vol.8
, pp. 172-175
-
-
Ciarapica, R.1
Russo, G.2
Verginelli, F.3
Raimondi, L.4
Donfrancesco, A.5
Rota, R.6
-
32
-
-
84868014011
-
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
-
Marchesi I, Fiorentino FP, Rizzolio F, Giordano A, Bagella L. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. Cell Cycle 2012; 11: 3828-3836.
-
(2012)
Cell Cycle
, vol.11
, pp. 3828-3836
-
-
Marchesi, I.1
Fiorentino, F.P.2
Rizzolio, F.3
Giordano, A.4
Bagella, L.5
-
33
-
-
41849112166
-
Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors
-
Mai A, Valente S, Cheng D, Perrone A, Ragno R, Simeoni S et al. Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors. ChemMedChem 2007; 2: 987-991.
-
(2007)
Chem Med Chem
, vol.2
, pp. 987-991
-
-
Mai, A.1
Valente, S.2
Cheng, D.3
Perrone, A.4
Ragno, R.5
Simeoni, S.6
-
34
-
-
84867395419
-
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells
-
Valente S, Lepore I, Dell'Aversana C, Tardugno M, Castellano S, Sbardella G et al. Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells. Biochimie 2012; 94: 2308-2313.
-
(2012)
Biochimie
, vol.94
, pp. 2308-2313
-
-
Valente, S.1
Lepore, I.2
Dell'Aversana, C.3
Tardugno, M.4
Castellano, S.5
Sbardella, G.6
-
35
-
-
44349086037
-
MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis
-
Wong CF, Tellam RL. MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J Biol Chem 2008; 283: 9836-9843.
-
(2008)
J Biol Chem
, vol.283
, pp. 9836-9843
-
-
Wong, C.F.1
Tellam, R.L.2
-
36
-
-
70349764482
-
Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells
-
Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36: 61-74.
-
(2009)
Mol Cell
, vol.36
, pp. 61-74
-
-
Juan, A.H.1
Kumar, R.M.2
Marx, J.G.3
Young, R.A.4
Sartorelli, V.5
-
37
-
-
72249104107
-
Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells
-
Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009; 139: 1303-1314.
-
(2009)
Cell
, vol.139
, pp. 1303-1314
-
-
Shen, X.1
Kim, W.2
Fujiwara, Y.3
Simon, M.D.4
Liu, Y.5
Mysliwiec, M.R.6
-
38
-
-
72249119297
-
Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells
-
Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009; 139: 1290-1302.
-
(2009)
Cell
, vol.139
, pp. 1290-1302
-
-
Peng, J.C.1
Valouev, A.2
Swigut, T.3
Zhang, J.4
Zhao, Y.5
Sidow, A.6
-
39
-
-
84869779376
-
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
-
Valentijn LJ, Koster J, Haneveld F, Aissa RA, van Sluis P, Broekmans ME et al. Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proc Natl Acad Sci USA 2012; 109: 19190-19195.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 19190-19195
-
-
Valentijn, L.J.1
Koster, J.2
Haneveld, F.3
Aissa, R.A.4
Van Sluis, P.5
Broekmans, M.E.6
-
40
-
-
34247625135
-
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
-
DOI 10.1101/gad.1524107
-
Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 2007; 21: 1050-1063. (Pubitemid 46686474)
-
(2007)
Genes and Development
, vol.21
, Issue.9
, pp. 1050-1063
-
-
Tan, J.1
Yang, X.2
Zhuang, L.3
Jiang, X.4
Chen, W.5
Puay, L.L.6
Karuturi, R.K.M.7
Tan, P.B.O.8
Liu, E.T.9
Yu, Q.10
-
41
-
-
77957357566
-
TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration
-
Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V et al. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7: 455-469.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 455-469
-
-
Palacios, D.1
Mozzetta, C.2
Consalvi, S.3
Caretti, G.4
Saccone, V.5
Proserpio, V.6
-
42
-
-
67649371461
-
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
-
Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009; 8: 1579-1588.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 1579-1588
-
-
Miranda, T.B.1
Cortez, C.C.2
Yoo, C.B.3
Liang, G.4
Abe, M.5
Kelly, T.K.6
-
43
-
-
84872568809
-
Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation
-
Gannon OM, Merida de Long L, Endo-Munoz L, Hazar-Rethinam M, Saunders NA. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin Cancer Res 2012; 19: 428-441.
-
(2012)
Clin Cancer Res
, vol.19
, pp. 428-441
-
-
Gannon, O.M.1
Merida De Long, L.2
Endo-Munoz, L.3
Hazar-Rethinam, M.4
Saunders, N.A.5
-
44
-
-
84871674660
-
Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
-
Benoit YD, Laursen KB, Witherspoon MS, Lipkin SM, Gudas LJ. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J cell physiol 2012; 228: 764-772.
-
(2012)
J Cell Physiol
, vol.228
, pp. 764-772
-
-
Benoit, Y.D.1
Laursen, K.B.2
Witherspoon, M.S.3
Lipkin, S.M.4
Gudas, L.J.5
-
45
-
-
84864458265
-
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)
-
Cheng LL, Itahana Y, Lei ZD, Chia NY, Wu Y, Yu Y et al. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res 2012; 18: 4201-4212.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4201-4212
-
-
Cheng, L.L.1
Itahana, Y.2
Lei, Z.D.3
Chia, N.Y.4
Wu, Y.5
Yu, Y.6
-
46
-
-
4143150844
-
Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1
-
DOI 10.1158/0008-5472.CAN-04-0844
-
Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K et al. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 2004; 64: 5539-5545. (Pubitemid 39095545)
-
(2004)
Cancer Research
, vol.64
, Issue.16
, pp. 5539-5545
-
-
Wachtel, M.1
Dettling, M.2
Koscielniak, E.3
Stegmaier, S.4
Treuner, J.5
Simon-Klingenstein, K.6
Buhlmann, P.7
Niggli, F.K.8
Schafer, B.W.9
-
47
-
-
59649085853
-
Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis: A report from the Children's Oncology Group
-
Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H et al. Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol 2009; 174: 550-564.
-
(2009)
Am J Pathol
, vol.174
, pp. 550-564
-
-
Davicioni, E.1
Anderson, M.J.2
Finckenstein, F.G.3
Lynch, J.C.4
Qualman, S.J.5
Shimada, H.6
-
48
-
-
53049083206
-
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations
-
Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI et al. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 2008; 68: 6587-6597.
-
(2008)
Cancer Res
, vol.68
, pp. 6587-6597
-
-
Ren, Y.X.1
Finckenstein, F.G.2
Abdueva, D.A.3
Shahbazian, V.4
Chung, B.5
Weinberg, K.I.6
-
49
-
-
0035807969
-
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
-
DOI 10.1073/pnas.251541198
-
Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1,a musclespecific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98: 14440-14445. (Pubitemid 33121410)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.25
, pp. 14440-14445
-
-
Gomes, M.D.1
Lecker, S.H.2
Jagoe, R.T.3
Navon, A.4
Goldberg, A.L.5
-
50
-
-
11144356337
-
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
-
DOI 10.1016/S0092-8674(04)00400-3, PII S0092867404004003
-
Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412. (Pubitemid 38534545)
-
(2004)
Cell
, vol.117
, Issue.3
, pp. 399-412
-
-
Sandri, M.1
Sandri, C.2
Gilbert, A.3
Skurk, C.4
Calabria, E.5
Picard, A.6
Walsh, K.7
Schiaffino, S.8
Lecker, S.H.9
Goldberg, A.L.10
-
51
-
-
77955739897
-
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer
-
Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO et al. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 2010; 70: 6497-6508.
-
(2010)
Cancer Res
, vol.70
, pp. 6497-6508
-
-
Cao, L.1
Yu, Y.2
Bilke, S.3
Walker, R.L.4
Mayeenuddin, L.H.5
Azorsa, D.O.6
-
52
-
-
84879523946
-
Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation
-
Jiang Y, Singh P, Yin H, Zhou YX, Gui Y, Wang DZ et al. Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation. J cell physiol 2013; 228: 1989-1995.
-
(2013)
J Cell Physiol
, vol.228
, pp. 1989-1995
-
-
Jiang, Y.1
Singh, P.2
Yin, H.3
Zhou, Y.X.4
Gui, Y.5
Wang, D.Z.6
-
53
-
-
63149106832
-
Differential cell death regulation between adult-unloaded and aged rat soleus muscle
-
Ogata T, Machida S, Oishi Y, Higuchi M, Muraoka I. Differential cell death regulation between adult-unloaded and aged rat soleus muscle. Mech ageing Dev 2009; 130: 328-336.
-
(2009)
Mech Ageing Dev
, vol.130
, pp. 328-336
-
-
Ogata, T.1
Machida, S.2
Oishi, Y.3
Higuchi, M.4
Muraoka, I.5
-
54
-
-
0037143626
-
Caspase 3 activity is required for skeletal muscle differentiation
-
DOI 10.1073/pnas.162172899
-
Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 2002; 99: 11025-11030. (Pubitemid 34920873)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.17
, pp. 11025-11030
-
-
Fernando, P.1
Kelly, J.F.2
Balazsi, K.3
Slack, R.S.4
Megeney, L.A.5
-
55
-
-
84860118049
-
Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation
-
Hunt LC, Upadhyay A, Jazayeri JA, Tudor EM, White JD. Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation. Skelet muscle 2011; 1: 17.
-
(2011)
Skelet Muscle
, vol.1
, pp. 17
-
-
Hunt, L.C.1
Upadhyay, A.2
Jazayeri, J.A.3
Tudor, E.M.4
White, J.D.5
-
56
-
-
77957244932
-
Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases
-
Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J et al. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 2010; 143: 35-45.
-
(2010)
Cell
, vol.143
, pp. 35-45
-
-
Moresi, V.1
Williams, A.H.2
Meadows, E.3
Flynn, J.M.4
Potthoff, M.J.5
McAnally, J.6
-
57
-
-
13244264946
-
Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase
-
DOI 10.1074/jbc.M411346200
-
Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J biol chem 2005; 280: 2847-2856. (Pubitemid 40189393)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.4
, pp. 2847-2856
-
-
Tintignac, L.A.1
Lagirand, J.2
Batonnet, S.3
Sirri, V.4
Leibovitch, M.P.5
Leibovitch, S.A.6
-
58
-
-
53549089902
-
Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise
-
Okada A, Ono Y, Nagatomi R, Kishimoto KN, Itoi E. Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise. Muscle Nerve 2008; 38: 1246-1253.
-
(2008)
Muscle Nerve
, vol.38
, pp. 1246-1253
-
-
Okada, A.1
Ono, Y.2
Nagatomi, R.3
Kishimoto, K.N.4
Itoi, E.5
-
59
-
-
63449129624
-
Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo
-
Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 2009; 4: e4973.
-
(2009)
PLoS One
, vol.4
-
-
Lagirand-Cantaloube, J.1
Cornille, K.2
Csibi, A.3
Batonnet-Pichon, S.4
Leibovitch, M.P.5
Leibovitch, S.A.6
-
60
-
-
65549097264
-
Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation
-
Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. J biol chem 2009; 284: 5488-5496.
-
(2009)
J Biol Chem
, vol.284
, pp. 5488-5496
-
-
Xie, P.1
Guo, S.2
Fan, Y.3
Zhang, H.4
Gu, D.5
Li, H.6
-
61
-
-
77949903838
-
Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: A report from the children's oncology group
-
Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche TJ. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group. J Clin Oncol 2010; 28: 1240-1246.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1240-1246
-
-
Davicioni, E.1
Anderson, J.R.2
Buckley, J.D.3
Meyer, W.H.4
Triche, T.J.5
-
62
-
-
36549038528
-
Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma
-
DOI 10.1016/j.bbrc.2007.11.017, PII S0006291X07023935
-
Kikuchi K, Tsuchiya K, Otabe O, Gotoh T, Tamura S, Katsumi Y et al. Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochem Biophys Res Commun 2008; 365: 568-574. (Pubitemid 350181685)
-
(2008)
Biochemical and Biophysical Research Communications
, vol.365
, Issue.3
, pp. 568-574
-
-
Kikuchi, K.1
Tsuchiya, K.2
Otabe, O.3
Gotoh, T.4
Tamura, S.5
Katsumi, Y.6
Yagyu, S.7
Tsubai-Shimizu, S.8
Miyachi, M.9
Iehara, T.10
Hosoi, H.11
-
63
-
-
80155126675
-
2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma
-
Ramirez-Peinado S, Alcazar-Limones F, Lagares-Tena L, El Mjiyad N, Caro-Maldonado A, Tirado OM et al. 2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res 2011; 71: 6796-6806.
-
(2011)
Cancer Res
, vol.71
, pp. 6796-6806
-
-
Ramirez-Peinado, S.1
Alcazar-Limones, F.2
Lagares-Tena, L.3
El Mjiyad, N.4
Caro-Maldonado, A.5
Tirado, O.M.6
-
64
-
-
84863954538
-
FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma
-
Crose LE, Etheridge KT, Chen C, Belyea B, Talbot LJ, Bentley RC et al. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma. Clin Cancer Res 2012; 18: 3780-3790.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 3780-3790
-
-
Crose, L.E.1
Etheridge, K.T.2
Chen, C.3
Belyea, B.4
Talbot, L.J.5
Bentley, R.C.6
-
65
-
-
79957913522
-
Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state
-
Lee MH, Jothi M, Gudkov AV, Mal AK. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state. Cancer Res 2011; 71: 3921-3931.
-
(2011)
Cancer Res
, vol.71
, pp. 3921-3931
-
-
Lee, M.H.1
Jothi, M.2
Gudkov, A.V.3
Mal, A.K.4
-
66
-
-
84862556419
-
Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation
-
Momparler RL, Idaghdour Y, Marquez VE, Momparler LF. Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation. Leuk Res 2012; 36: 1049-1054.
-
(2012)
Leuk Res
, vol.36
, pp. 1049-1054
-
-
Momparler, R.L.1
Idaghdour, Y.2
Marquez, V.E.3
Momparler, L.F.4
-
67
-
-
79953108690
-
Epigenetics in cancer: What's the future?
-
Boumber Y, Issa JP. Epigenetics in cancer: what's the future? Oncology 2012; 25: 220-226228.
-
(2012)
Oncology
, vol.25
, pp. 220-226228
-
-
Boumber, Y.1
Issa, J.P.2
-
68
-
-
84861134077
-
Epigenetic changes in pediatric solid tumors: Promising new targets
-
Lawlor ER, Thiele CJ. Epigenetic changes in pediatric solid tumors: promising new targets. Clin Cancer Res 2012; 18: 2768-2779.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 2768-2779
-
-
Lawlor, E.R.1
Thiele, C.J.2
-
69
-
-
79954471872
-
EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression
-
Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 2011; 9: 418-429.
-
(2011)
Mol Cancer Res
, vol.9
, pp. 418-429
-
-
Fan, T.1
Jiang, S.2
Chung, N.3
Alikhan, A.4
Ni, C.5
Lee, C.C.6
-
70
-
-
84862161257
-
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
-
Chng KR, Chang CW, Tan SK, Yang C, Hong SZ, Sng NY et al. A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. Embo J 2012; 31: 2810-2823.
-
(2012)
Embo J
, vol.31
, pp. 2810-2823
-
-
Chng, K.R.1
Chang, C.W.2
Tan, S.K.3
Yang, C.4
Hong, S.Z.5
Sng, N.Y.6
-
71
-
-
3042763342
-
P38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci
-
DOI 10.1038/ng1378
-
Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat genet 2004; 36: 738-743. (Pubitemid 38886636)
-
(2004)
Nature Genetics
, vol.36
, Issue.7
, pp. 738-743
-
-
Simone, C.1
Forcales, S.V.2
Hill, D.A.3
Imbalzano, A.N.4
Latella, L.5
Puri, P.L.6
-
72
-
-
0034096583
-
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
-
DOI 10.1016/S0166-3542(00)00066-8, PII S0166354200000668
-
Bray M, Driscoll J, Huggins JW. Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor. Antiviral Res 2000; 45: 135-147. (Pubitemid 30156782)
-
(2000)
Antiviral Research
, vol.45
, Issue.2
, pp. 135-147
-
-
Bray, M.1
Driscoll, J.2
Huggins, J.W.3
-
73
-
-
45549103902
-
High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma
-
DOI 10.1136/jcp.2007.054262
-
Vekony H, Raaphorst FM, Otte AP, van Lohuizen M, Leemans CR, van der Waal I et al. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. J Clin Pathol 2008; 61: 744-749. (Pubitemid 351859967)
-
(2008)
Journal of Clinical Pathology
, vol.61
, Issue.6
, pp. 744-749
-
-
Vekony, H.1
Raaphorst, F.M.2
Otte, A.P.3
Van Lohuizen, M.4
Leemans, C.R.5
Van Der Waal, I.6
Bloemena, E.7
|